Regulatory Approvals of Pediatr ic Oncology Drugs : Prev ious
暂无分享,去创建一个
[1] J. Milone,et al. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse , 2004, Cancer Chemotherapy and Pharmacology.
[2] W. Bowman,et al. VM26 therapy in children with drug-refractory lymphocytic leukemia , 2004, Cancer Chemotherapy and Pharmacology.
[3] S. Hirschfeld,et al. Oncology drug development: United States Food and Drug Administration perspective. , 2002, Critical reviews in oncology/hematology.
[4] S. Hirschfeld,et al. Pediatric oncology: regulatory initiatives. , 2000, The oncologist.
[5] D. Stram,et al. Allogeneic versus autologous purged bone marrow transplantation for neuroblastoma: a report from the Childrens Cancer Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] A. Cantor,et al. Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] H. Issacs,et al. Occult malignancy in neonatal sacrococcygeal teratomas. A report from a Combined Pediatric Oncology Group and Children's Cancer Group study. , 1993, The American journal of pediatric hematology/oncology.
[8] A. Cantor,et al. Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] A. Lasorella,et al. Principles of Cancer Chemotherapy in Children , 1992 .
[10] R. Simon,et al. Influence of doxorubicin dose intensity on response and outcome for patients with osteogenic sarcoma and Ewing's sarcoma. , 1991, Journal of the National Cancer Institute.
[11] B. Leyland-Jones,et al. Azacitidine: 10 years later. , 1987, Cancer treatment reports.
[12] J. Anderson,et al. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial. , 1981, Cancer treatment reports.
[13] R. Aur,et al. VM‐26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia , 1980, Cancer.
[14] R. Aur,et al. Combined VM‐26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia , 1980, Cancer.